DEPLOYThe reference layer for physical AI

Robot model

RingConn (Gen 2 / Gen 3)

RingConn, a Shenzhen-based Chinese smart-ring maker, is the subscription-free anchor of the biometric ring market and a deliberate counterpoint to Oura and Whoop, recorded in the biometric form factor. Its Gen 2 ring sells for about $279 with a 10-to-12-day battery and a charging case extending to about 150 days, pairing PPG, skin-temperature, blood-oxygen, and accelerometer sensors with sleep, heart-rate, and a deep-learning sleep-apnea screening feature, and all standard features are free for life with no membership, the core positioning of the brand; the Gen 2 raised about $4.4 million on Kickstarter and the Gen 3 launched in late May 2026 with more than $10 million in pre-orders in about twenty days. Two corrections to common priors are load-bearing. First, RingConn's sleep-apnea and apnea-hypopnea-index feature is not FDA-cleared but wellness and pre-diagnostic: the company's own launch release says it is actively pursuing clearance and carries a not-intended-to-diagnose disclaimer, and the widely repeated claim that RingConn received FDA clearance for blood oxygen or sleep apnea appears only on aggregator sites and conflates it with the Happy Ring, the genuinely FDA-cleared sleep-apnea ring, so RingConn is recorded as not cleared with its 90.7-percent accuracy a vendor claim. Second, RingConn is not subject to an active US import ban: although it was a co-respondent found to infringe in Oura's International Trade Commission case over patent 11,868,178, it settled and Oura granted it a multi-year license to keep selling in the US, so only Ultrahuman's Ring Air carries the active ban. Its clinical-validation posture is wellness-grade and claim-heavy, and its founder identity, funding, and cumulative unit shipments are not reliably verified.

RingConn (Gen 2 / Gen 3) is a biometric robot built by

Machine-readable surfaces

Form factor
biometric
Maturity stage
commercial
Lifecycle
active
Deployments
0
ID
da93282e-f971-48ed-aa6a-0c795348314d

Specs

notes
[object Object],[object Object],[object Object],[object Object]
specs
RingConn Gen 2 (~$279) + Gen 2 Air + Gen 3 (late May 2026). Sensors: PPG, skin temperature, SpO2, accelerometer. 10-12 day battery (charging case to ~150 days). AI/health: sleep + HR/HRV + 'sleep apnea / AHI' screening (deep-learning, claimed 90.7% accuracy). SUBSCRIPTION-FREE: all standard features free for life (the core positioning vs Oura/Whoop). Chinese (Shenzhen).
formFactor
biometric (biometric-primary smart ring + AI augmentation; SUBSCRIPTION-FREE)

Supply chain

No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this model’s suppliers.

Suppliers appear here when verified with at least two strong sources (maker-official / IR / regulatory / standards-body / verified tier-2). Sources are append-only; corrections add new sources rather than rewrite history.

Sources (4)

  1. https://www.prnewswire.com/news-releases/ringconn-launches-gen-2-smart-ring-pioneering-sleep-apnea-detection-with-unmatched-10---12-days-battery-life-302212578.html
  2. https://ouraring.com/blog/oura-itc-case/
  3. https://chinabizinsider.com/shenzhens-ringconn-challenges-oura-dominance-as-smart-ring-shipments-surge-49-at-ces-2026/
  4. https://www.prnewswire.com/news-releases/ringconn-gen-3-smart-ring-officially-launches-302785564.html

Common questions

What is RingConn (Gen 2 / Gen 3)?
RingConn, a Shenzhen-based Chinese smart-ring maker, is the subscription-free anchor of the biometric ring market and a deliberate counterpoint to Oura and Whoop, recorded in the biometric form factor. Its Gen 2 ring sells for about $279 with a 10-to-12-day battery and a charging case extending to about 150 days, pairing PPG, skin-temperature, blood-oxygen, and accelerometer sensors with sleep, heart-rate, and a deep-learning sleep-apnea screening feature, and all standard features are free for life with no membership, the core positioning of the brand; the Gen 2 raised about $4.4 million on Kickstarter and the Gen 3 launched in late May 2026 with more than $10 million in pre-orders in about twenty days. Two corrections to common priors are load-bearing. First, RingConn's sleep-apnea and apnea-hypopnea-index feature is not FDA-cleared but wellness and pre-diagnostic: the company's own launch release says it is actively pursuing clearance and carries a not-intended-to-diagnose disclaimer, and the widely repeated claim that RingConn received FDA clearance for blood oxygen or sleep apnea appears only on aggregator sites and conflates it with the Happy Ring, the genuinely FDA-cleared sleep-apnea ring, so RingConn is recorded as not cleared with its 90.7-percent accuracy a vendor claim. Second, RingConn is not subject to an active US import ban: although it was a co-respondent found to infringe in Oura's International Trade Commission case over patent 11,868,178, it settled and Oura granted it a multi-year license to keep selling in the US, so only Ultrahuman's Ring Air carries the active ban. Its clinical-validation posture is wellness-grade and claim-heavy, and its founder identity, funding, and cumulative unit shipments are not reliably verified.
Who makes RingConn (Gen 2 / Gen 3)?
RingConn (Gen 2 / Gen 3) is made by RingConn, based in Shenzhen, China, founded in 2021.
Where is RingConn (Gen 2 / Gen 3) deployed?
No verified deployments of RingConn (Gen 2 / Gen 3) are currently on the DEPLOY registry. DEPLOY records deployments only when verified at a named site with a primary source; absence may reflect pre-deployment, research, or manufacturer-internal use.
What is RingConn (Gen 2 / Gen 3)'s maturity stage?
RingConn (Gen 2 / Gen 3) is at the commercial stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Commercial stage means production-grade deployments are operating at named customer sites.

Related biometric